News Archives - Page 84 of 87

ThursdayJun 16, 2022 2:30 pm

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces $5M Share Repurchase Program

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors has authorized the repurchase of up to $5 million of its outstanding common shares as market conditions and the company’s liquidity warrant. “We believe that the potential to repurchase our shares at these levels represents a compelling opportunity to deploy available cash to drive shareholder value,” said Luis Merchan, Flora’s chairman and CEO. “Flora continues to move assertively to execute its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses. We are confident…

WednesdayJun 15, 2022 12:08 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) to Join Russell 3000(R) Index, Expand Story Among Investment Community

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced that it will be added as a member of the Russell 3000(R) index at the conclusion of the 2022 Russell indexes annual reconstitution. This is effective after the U.S. market opens on June 27, 2022, according to a preliminary list of additions posted on June 3, 2022. “Cepton is excited to be joining the Russell 3000(R) index as it enables us to expand awareness of our story among the investment community as we continue to execute against our milestones generating long-term stakeholder value,” said…

TuesdayJun 14, 2022 4:40 pm

TinyGemsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Added to PMLS Menu of Testing Services

Premier Medical Laboratory Services (“PMLS”), a nation-leading advanced medical diagnostics lab, today announced that it has added Aditxt’s (NASDAQ: ADTX) AditxtScore(TM) to its menu of testing services. AditxtScore provides more clarity regarding a patient’s individual immunity profile and allows patients to know their level of protection that an immune response to the virus or vaccination has provided them. “As new variants emerge, we want to equip physicians with the most advanced tests that allow a comprehensive view of their patient’s health status,” said Kevin Murdock, CEO of Premier Medical Laboratory Services. “With AditxtScore, individuals can make more informed decisions about…

TuesdayJun 14, 2022 3:36 pm

TinyGemsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Reaches Agreement with Philip Morris International Inc. (NYSE: PM) for International Electronic Nicotine Delivery System Product Distribution

Kaival Brands (NASDAQ: KAVL), the U.S. distributor of all products manufactured by Bidi Vapor LLC, which are intended for legal-age nicotine users, has inked an international licensing agreement with Philip Morris Products S.A. (“PMPSA”) for the development and distribution of electronic nicotine delivery system ("ENDS") products. Philip Morris Products is a wholly owned affiliate of Philip Morris International Inc. (NYSE: PM), and the agreement, which was finalized on June 13, 2022, covers products for markets outside of the United States. According to the announcement, the agreement between Kaival and PMPSA grants the latter the rights to manufacture, promote, sell and…

FridayJun 10, 2022 4:02 pm

TinyGemsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow to Take the Spotlight at Kennedy Space Center

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that its Robot Roadshow will land in Florida at the Kennedy Space Center from 10 a.m. to 2 p.m. ET on June 17, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow has completed 45 landings in 16 states and Washington, D.C. to date. Knightscope’s crime-fighting robots tour the U.S. in a space-age, NASA-like ‘pod’ allowing attendees to experience…

FridayJun 10, 2022 12:40 pm

TinyGemsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Completion of Key Milestones Position It for Success

Flora Growth Corp. (NASDAQ: FLGC) recently announced financial and operating results for the 2021 fiscal year that show the success of its efforts as revenues and profits begin what is expected to be a rapid climb. “The year-end financial results show about $9 million in revenues, which is ‘significantly higher’ than those reported the prior year before the law change and Flora’s IPO launch on the Nasdaq Capital Market. The report maintains the company’s outlook for ending 2022 with revenues of $35 million to $45 million, which would be growth of between 288% and 400% over 2021. Much of Flora’s…

FridayJun 10, 2022 10:48 am

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Awarded Board Approval for CYB003 Phase 1/2a Clinical Trial

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, received Institutional Review Board (“IRB”) approval to begin its planned phase 1/2a clinical trial. The trial, the first-in-human phase 1/2a trial evaluating CYBN’s proprietary deuterated psilocybin analog CYB003, is slated to begin in mid-2022.The study will evaluate CYB003 for the treatment of major depressive disorder (“MDD”). Cybin applied for IRB approval just last month. According to the announcement, Cybin wholly owned subsidiary Cybin IRL Limited has partnered with Clinilabs Drug Development Corporation to conduct the randomized, double-blind, placebo-controlled study. The study involves participants receiving two administrations of…

ThursdayJun 09, 2022 2:41 pm

TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Engages IBN for Corporate Communications Expertise

Aditxt (NASDAQ: ADTX), a biotech innovation company, today announced that it has selected the corporate communications expertise of IBN (“InvestorBrandNetwork”), a multifaceted financial news and publishing company for private and public entities. As part of the relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs, and other outreach tools to generate greater awareness for Aditxt. “The potential market opportunities presented by immune monitoring and reprogramming are extensive. Through its work in the COVID-19 testing market with AditxtScore(TM), Aditxt demonstrated this potential. The company is now…

ThursdayJun 09, 2022 2:21 pm

TinyGemsBreaks – SRAX Inc. (NASDAQ: SRAX), Rogue Station Companies Inc./Everdime Inc. (RGST) Enter Partnership to Enhance Investor Communications

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has entered a partnership with Rogue Station Companies/Everdime (OTC: RGST). Through SRAX, RGST, a crypto and blockchain development company building the technology bridge that connects what is real and the new augmented reality within the metaverse, will have the ability to further reach its community through sophisticated solutions. “The RGST/Everdime team warmly welcomes our recent partnership with SRAX,” said RGST CEO Sandor Miklos. “As our company continues BETA testing its apps and prepares to launch its token and…

ThursdayJun 09, 2022 2:11 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and further enhance BayMedica’s growing product portfolio,” said Shane Johnson, MD, SVP and general manager of BayMedica. “THCV is one of the few rare cannabinoids that has been researched in early clinical trials for various therapeutic effects, fueling significant interest by end-product manufacturers and consumers alike.…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News